IP Library Granted Patent US 7,700,080
Granted Patent B2
US 7,700,080 · App. 10/472,726 · Granted Apr 20, 2010

Method of suppressing melanin production by metal chelates of lipoyl amino acid derivatives

Assignee: Senju Pharmaceutical Co., Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,700,080
App. No.
10/472,726
Granted
Apr 20, 2010
Kind
B2
Abstract

A novel α-lipoic acid derivative represented by the following formula (I). It has a tyrosinase inhibiting activity, melanin production inhibitory activity, and elastase inhibiting activity. (I) (In the formula, M represents a metal and A denotes an amino acid residue bonded through the nitrogen atom.).

Claims (4)

1. A method of suppressing melanin production in human skin comprising, topically administering to a human an effective amount of an N-(6,8-dimercaptooctanoyl)amino acid metal chelate compound represented by the following formula (I),

wherein M denotes a zinc, and A denotes an amino acid which is bound via the amino acid nitrogen; or a pharmacologically acceptable salt thereof, wherein the amino acid is selected from the group consisting of aminomethylcyclohexanoic acid, anthranilic acid, aminoethanesulfonic acid, glycine, alanine, valine, leucine, isoleucine, seine, threonine, tyrosine, cysteine, methionine, aspartic acid, asparagine, glutamic acid, glutamine, arginine, lysine, histidine, phenylalanine, tryptophan, β-alanine, γ-amino-n-butyric acid, carnitine, 5-aminolevulinic acid, 5-aminovaleric acid, and 6-aminohexanoic acid, wherein the human is in need of suppression of melanin production.

2. The method of claim 1 , wherein the human is in need of whitening the skin.

3. The method of claim 1 , wherein the human is in need of inhibiting elastase.

Assignments (2)
CHANGE OF ADDRESS Recorded Aug 24, 2018
From: SENJU PHARMACEUTICAL CO., LTD.
To: SENJU PHARMACEUTICAL CO., LTD.
Reel/Frame 046835/0350 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 17, 2003
From: OGATA, KAZUMI; SAKAUE, TAKAHIRO; ITO, KAZUHIKO
To: SENJU PHARMACEUTICAL CO., LTD.
Reel/Frame 014939/0408 →
Priority Claims (1)
JP 2001-078571 · Mar 19, 2001 · national
Continuity (1)
Related Publication 20040092586A1 · May 13, 2004